Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Cultivated Limbal Stem Cells Transplantation

· Holostem s.r.l.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Cultivated Limbal Stem Cells Transplantation, covering 2022-04-01 to 2022-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency [Phase 4]

See pricing